AI-ACCELERATED DRUG DISCOVERY
We are delighted to inform you that our CEO Alan Nafiiev and CSO Semen Yesylevskyy, will be attending the Bio-Europe Spring conference from March 20-22 in Basel, Switzerland, to present the latest advancements in Receptor.AI's precision medicine platform.
We cordially invite our partners, including organizations specializing in assay development, target identification, and validation, as well as experts in structural biology, to join us at this esteemed event.
Our goal is to foster collaboration and explore novel opportunities in the discovery of small molecules, even for the most intricate indications. We look forward to engaging with you and contributing to the ongoing progress in the field of precision medicine.
